Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 710 (USA) (Dr. Silva)
· consented 2013-11-16
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild ATRIOVENTRICULAR BLOCK FIRST DEGREE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-10 (study day 115.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-10 (study day 115.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.